A detailed history of Glen Eagle Advisors, LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 17 shares of AVNS stock, worth $270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 17 -0.0%
Holding current value
$270
Previous $339,000 20.65%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 03, 2024

BUY
$17.97 - $22.68 $305 - $385
17 New
17 $338,000
Q2 2023

Aug 13, 2024

SELL
$22.53 - $30.98 $67 - $92
-3 Reduced 15.0%
17 $435,000
Q1 2023

Aug 13, 2024

BUY
$26.92 - $31.75 $80 - $95
3 Added 17.65%
20 $595,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $740M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.